XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial

OBJECTIVES: To investigate whether XueBiJing injection improves clinical outcomes in critically ill patients with severe community-acquired pneumonia. DESIGN: Prospective, randomized, controlled study. SETTING: Thirty-three hospitals in China. PATIENTS: A total of 710 adults 18–75 years old with sev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care Med
Autori principali: Song, Yuanlin, Yao, Chen, Yao, Yongming, Han, Hui, Zhao, Xiaodong, Yu, Kaijiang, Liu, Luyi, Xu, Ying, Liu, Zhongmin, Zhou, Qingshan, Wang, Ying, Ma, Zhuang, Zheng, Youguang, Wu, Dawei, Tang, Zhongzhi, Zhang, Minzhou, Pan, Shuming, Chai, Yanfen, Song, Yan, Zhang, Jian, Pan, Lei, Liu, Yi, Yu, He, Yu, Xuezhong, Zhang, Hong, Wang, Xiaoge, Du, Zhaohui, Wan, Xianyao, Tang, Yijun, Tian, Yingping, Zhu, Yimin, Wang, Hongliang, Yan, Xiaoyan, Liu, Zhi, Zhang, Boli, Zhong, Nanshan, Shang, Hongcai, Bai, Chunxue
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2019
Soggetti:
Online Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727951/
https://ncbi.nlm.nih.gov/pubmed/31162191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000003842
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi